{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:27:29Z","timestamp":1698690449098},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1735,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1365-2516.2010.02427.x","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T07:46:54Z","timestamp":1291189614000},"page":"422-427","source":"Crossref","is-referenced-by-count":15,"title":["Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela"],"prefix":"10.1111","volume":"17","author":[{"given":"A.","family":"BOADAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"FERN\u00c1NDEZ-PALAZZI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. B.","family":"DE BOSCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"CEDE\u00d1O","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"RUIZ-S\u00c1EZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,1]]},"reference":[{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/9780470757260.ch27","volume-title":"Inhibitors in Patients with Haemophilia","author":"Hvid","year":"2002"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2000-8463","article-title":"Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors","volume":"26","author":"Ingerslev","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2516.2007.01632.x","article-title":"Some recent developments regarding arthropathy and inhibitors in haemophilia","volume":"14","author":"Rodriguez-Merchan","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2516.2007.01518.x","article-title":"European study on orthopaedic status of haemophilia patients with inhibitors","volume":"13","author":"Morfini","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-03-0941","article-title":"Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group","volume":"102","author":"Gringeri","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01931.x","article-title":"Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0038-1653436","article-title":"Activated factor IX complex in treatment of surgical cases of hemophilia A with inhibitors","volume":"46","author":"Hanna","year":"1981","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2010.02427.x-BIB8|cit8","first-page":"118","article-title":"Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa","volume":"26","author":"Ingerslev","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1055\/s-0038-1656122","article-title":"Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity","volume":"77","author":"Negrier","year":"1997","journal-title":"Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2010.02427.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2516.2004.00941.x","article-title":"Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement","volume":"10","author":"Rodriguez-Merchan","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2516.2007.01617.x","article-title":"Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature","volume":"14","author":"Obergfell","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2516.2009.02149.x","article-title":"Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa","volume":"16","author":"Takedani","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2516.2008.01840.x","article-title":"Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care","volume":"15","author":"Teitel","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB14|cit14","first-page":"227","article-title":"Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective","volume":"68","author":"Perez","year":"2008","journal-title":"Medicina (B Aires)"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2516.1995.tb00104.x","article-title":"Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia","volume":"1","author":"Rickard","year":"1995","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2010.02427.x-BIB16|cit16","article-title":"Orthopaedic surgery in two haemophilic patients with high-response inhibitors","volume":"5","author":"Quintana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V72.1.116.bloodjournal721116","article-title":"Further specificity characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease","volume":"72","author":"Lopez-Fernandez","year":"1988","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00001721-199803000-00002","article-title":"Clinical experience with recombinant factor VIIa","volume":"9","author":"Lusher","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/9780470757260.ch28","volume-title":"Inhibitors in Patients with Haemophilia","author":"White","year":"2002"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(88)90259-0","article-title":"Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy","volume":"2","author":"Hedner","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0037-1615357","article-title":"Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery","volume":"80","author":"Shapiro","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB23|cit23","first-page":"117","article-title":"Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2516.2008.01952.x","article-title":"Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors","volume":"15","author":"Giangrande","year":"2009","journal-title":"Haemophilia"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2010.02427.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2516.2004.00938.x","article-title":"Surgery in haemophilic patients with inhibitor: 20\u2003years of experience","volume":"10","author":"Quintana-Molina","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2516.1998.440564.x","article-title":"Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group","volume":"4","author":"Schulman","year":"1998","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2516.2010.02427.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2516.2006.01368.x","article-title":"Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII\/FIX, desmopressin and antifibrinolytics","volume":"12","author":"Berntorp","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB28|cit28","first-page":"157","volume-title":"Hemophilia and von Willebrand\u2019s Disease in the 1990s","author":"Fernandez-Palazzi","year":"1991"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB29|cit29","unstructured":"Fernandez-Palazzi F Rivas S Marulanda A Boada A de Saez AR de Bosch NB On two extensive surgeries of giant soft tissue haemophilic pseudotumors of the thigh (abstract)"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2516.2003.00857.x","article-title":"Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII\/IX","volume":"10","author":"Tjonnfjord","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1365-2516.2008.01873.x","article-title":"Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors","volume":"15","author":"Lauroua","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/9780470987124.ch14","volume-title":"Text of Hemophilia","author":"Negrier","year":"2005"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB33|cit33","unstructured":"Word Federation of Hemophilia Guidelines for the Management of Hemophilia World Federation of Hemophilia http:\/\/www.wfh.org\/2\/docs\/Publications\/Diagnosis_and_Treatment\/Guidelines_Mng_Hemophilia.pdf"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2010.02427.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2516.2005.01152.x","article-title":"Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach","volume":"11","author":"Ludlam","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MBC.0b013e3283001cdc","article-title":"Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial","volume":"19","author":"Young","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2516.2009.02082.x","article-title":"Thrombin generation testing in haemophilia comprehensive care centres","volume":"16","author":"Dargaud","year":"2010","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02427.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1053\/j.seminhematol.2008.03.009","article-title":"Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors","volume":"45","author":"Jimenez-Yuste","year":"2008","journal-title":"Semin Hematol"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2010.02427.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2516.2010.02427.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T10:11:16Z","timestamp":1625393476000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2010.02427.x"}},"subtitle":["ELECTIVE SURGERY IN INHIBITOR PATIENTS"],"short-title":[],"issued":{"date-parts":[[2010,12,1]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02427.x","relation":{},"ISSN":["1351-8216"],"issn-type":[{"value":"1351-8216","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,1]]}}}